Allan Oberman
executiveMale0.0Global Dominance: 0.00%
Allan Oberman is the Chief Executive Officer of Apotex Inc., Canada’s largest pharmaceutical company, which is planning a $1-billion initial public offering. With a background as a former executive at Teva Pharmaceutical Industries, Oberman brings extensive experience in the generic drug sector. He has been instrumental in leading Apotex's strategic direction towards producing affordable medicines and expanding its product portfolio.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Allan Oberman was the chief executive officer of Apotex before being replaced in March.
Apotex expected to fetch $10-billion valuation as drugmaker files to go public on TSXThe Globe and Mail·
Canada· 2026-05-28
Canada· 2026-05-28
Allan Oberman is the CEO of Apotex and is leading a marketing campaign for the company.
Apotex plans $1-billion initial public offeringThe Globe and Mail·Canada· 2026-02-25
Canada· 2026-02-25
